Does Bicycle Therapeutics PLC (BCYC) Have What it Takes to be in Your Portfolio Wednesday?

Bicycle Therapeutics PLC (BCYC) is around the top of the Biotechnology industry according to InvestorsObserver. BCYC received an overall rating of 68, which means that it scores higher than 68 percent of all stocks. Bicycle Therapeutics PLC also achieved a score of 80 in the Biotechnology industry, putting it above 80 percent of Biotechnology stocks. Biotechnology is ranked 16 out of the 148 industries.

BCYC has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on BCYC!

See Full BCYC Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 68 means the stock is more attractive than 68 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Bicycle Therapeutics PLC Stock Today?

Bicycle Therapeutics PLC (BCYC) stock is lower by -2.19% while the S&P 500 is up 0.77% as of 11:14 AM on Wednesday, Mar 6. BCYC has fallen -$0.54 from the previous closing price of $24.66 on volume of 22,912 shares. Over the past year the S&P 500 has risen 28.38% while BCYC is up 11.77%. BCYC lost -$5.08 per share the over the last 12 months. Click Here to get the full Stock Report for Bicycle Therapeutics PLC stock.